摘要
目的:探究行精准放疗治疗肝癌患者短期进展风险预测中应用增强CT图像纹理分析技术的价值。方法:选取2019年3月~2020年11月在齐齐哈尔医学院附属第三医院接受精准放疗治疗的原发性肝癌患者73例为对象,并利用增强CT图像纹理分析技术对CT轴位图像予以分析。结果:在肝癌精准放疗治疗3个月内PLC患者发生肿瘤局灶性进展和未发展进展的占比分别为57.53%、42.47%。两组在均数、熵值、不均匀度方面则有统计学差异(P<0.05)。两组在峰度、偏度方面则无统计学差异(P>0.05)。结论:在预测行精准放疗治疗的PLC患者时,将增强CT图像纹理分析技术应用其中,对患者短期进展风险预测具有较高的价值。
Objective:To explore the value of enhanced CT image texture analysis technology in the short-term risk prediction of liver cancer patients undergoing precision radiotherapy.Methods:A total of 73 patients with primary liver cancer who received precision radiotherapy in our hospital from March 2019 to November 2020 were selected as subjects.All patients underwent enhanced CT scans of the upper abdomen for follow-up.The CT image texture analysis technology analyzes the CT axial images.Results:Within 3 months of precision radiotherapy for liver cancer,the proportions of focal and undeveloped tumor progression in PLC patients were 57.53%and 42.47%.There was a statistical difference in the mean,the entropy and unevenness between the two groups(P<0.05).There was no statistical difference in kurtosis and skewness between the two groups(P>0.05).Conclusion:When predicting PLC patients undergoing precision radiotherapy,the application of enhanced CT image texture analysis technology has certain application and promotion value.
作者
李京
李阳
关可欣
佟旭
罗福申
张拓
徐倩倩
滕野
LI Jing;LI Yang;GUAN Ke-xin;TONG Xu;LUO Fu-shen;ZHANG Tuo;XU Qian-qian;TENG Ye(Department of Radiotherapy,the Third Affiliated Hospital of Qiqihar Medical University,Heilongjiang Qiqihar 161000;Department of Breast Milk Surgery,the First Hospital of Qiqihar,Heilongjiang Qiqihar 161000;The First Department of General Surgery,the First Hospital of Qiqihar,Heilongjiang Qiqihar 161000)
出处
《中国医疗器械信息》
2021年第21期49-50,172,共3页
China Medical Device Information
基金
齐齐哈尔市科技计划创新激励项目(项目名称:动脉期纹理分析技术在肝癌精准放疗中的临床研究
项目编号:CSFGG-2020001)。
关键词
肝癌
增强CT图像纹理分析技术
liver cancer
enhanced CT image texture analysis technology
